Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Thrombosis Research

• Publication date

  1984-06-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0049-3848(84)90255-XPMID 6377575
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prothrombin Habana: a new dysfunctional molecule of human prothrombin associated with a true prothrombin deficiency

  1983cited by this paper
• Activation of human prothrombin by stoichiometric levels of staphylocoagulase.

  1983cited by this paper
• A new variant of human prothrombin: prothrombin Metz, demonstration in a family showing double heterozygosity for congenital hypoprothrombinemia and dysprothrombinemia.

  1982cited by this paper
• CHARACTERIZATION OF A VARIANT OF HUMAN PROTHROMBIN: PROTHROMBIN MADRID

  1981cited by this paper
• Prothrombin gainesville. A dysprothrombinemia in a pair of identical twins

  1981cited by this paper
• THROMBIN SPECIFICITY *

  1981cited by this paper
• Prothrombin Houston: a dysprothrombin identifiable by crossed immunoelectrofocusing and abnormal Echis carinatus venom activation.

  1980cited by this paper
• Identification of a congenital dysthrombin, thrombin Quick.

  1980cited by this paper
• Activation of prothrombin Barcelona. Evidence for active high molecular weight intermediates.

  1979cited by this paper
• Prothrombin Madrid : a new familial abnormality of prothrombin.

  1979cited by this paper
• Purification and partial characterization of a new variant of human prothrombin: prothrombin Metz

  1979cited by this paper
• The isolation and characterization of a specific antibody population directed against the prothrombin activation fragments F2 and F1 + 2.

  1979cited by this paper
• Prothrombin Quick. A newly identified dysprothrombinemia.

  1978cited by this paper
• Prothrombin Molise: a "new" congenital dysprothrombinemia, double heterozygosis with an abnormal prothrombin and "true" prothrombin deficiency.

  1978cited by this paper
• Prothrombin structure, activation, and biosynthesis.

  1977cited by this paper
• Human thrombins. Production, evaluation, and properties of alpha-thrombin.

  1977cited by this paper
• The mechanism of activation of bovine prothrombin by an activator isolated from Echis carinatus venon and characterization of the new active intermediates.

  1976cited by this paper
• The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin.

  1975cited by this paper
• Activation of human prothrombin by a procoagulant fraction from the venom of Echis carinatus. Identification of a high molecular weight intermediate with thrombin activity.

  1975cited by this paper
• Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase.

  1975cited by this paper
• Prothrombin Brussels, a new congenital defective protein.

  1974cited by this paper
• Prothrombin padua: a "new" congenital dysprothrombinemia.

  1974cited by this paper
• Human Coumarin Prothrombin

  1973cited by this paper
• Congenital abnormality of the prothrombin molecule (factor II) in four siblings: prothrombin Barcelona.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper
• Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin.

  1969cited by this paper
• [Comparative study of the levels of staphylocoagulase cofactor (coagulase reacting factor) and of factor II (prothrombin) in various conditions].

  1966cited by this paper
• Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

  1966cited by this paper
• ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.

  1965cited by this paper
• DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS *

  1964cited by this paper
• The Preparation and Some Properties of Fibrinogen Precipitated from Human Plasma by Glycine.∗

  1963cited by this paper
• A Brain Extract as a Substitute for Platelet Suspensions in the Thromboplastin Generation Test

  1954cited by this paper
• A quantitative one-stage method for the assay of prothrombin.

  1949cited by this paper
• Two-stage procedure for the quantitative determination of prothrombin concentration.

  1949cited by this paper

• Thrombin: An Approach to Developing a Higher-Order Reference Material and Reference Measurement Procedure for Substance Identity, Amount, and Biological Activities

  2020cites this paper
• derived from a human prothrombin variant Functional characterization of thrombin Salakta: an abnormal thrombin

  2011cites this paper
• Congenital Prothrombin Deficiency

  2009cites this paper
• Prothrombin Segovia: a new congenital abnormality of prothrombin.

  2009cites this paper
• Congenital prothrombin deficiency.

  2009cites this paper
• Congenital bleeding disorders of the vitamin K-dependent clotting factors.

  2008cites this paper
• Hereditäre Dysprothrombinämie mit geringer Blutungsneigung (Prothrombin Magdeburg)

  2008cites this paper
• A critical role for Gly25 in the B chain of human thrombin

  2005cites this paper
• Red blood cells from patients with homozygous sickle cell disease provide a catalytic surface for factor Va inactivation by activated protein C

  2002cites this paper
• Kringles of the plasminogen--prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site.

  2001cites this paper
• Severe acquired vitamin K deficiency: a hypothesis for rapid response to therapy.

  2000cites this paper
• Frequent factor II G20210A mutation in idiopathic portal vein thrombosis.

  1999cites this paper
• Inhibition of Thrombin-catalyzed Factor V Activation by Bothrojaracin

  1998cites this paper
• Congenital deficiencies and abnormalities of prothrombin.

  1998cites this paper
• Prothrombin Marburg--a dysfunctional coagulation protein.

  1997cites this paper
• Phosphatidylserine exposure and aminophospholipid translocase activity in Rh-deficient erythrocytes.

  1997cites this paper
• Purification and characterization of a variant of human prothrombin: prothrombin Segovia.

  1997cites this paper
• Sickle cell disease: relation between procoagulant activity of red blood cells from different phenotypes and in vivo blood coagulation activation

  1997cites this paper
• Increased Procoagulant Activity of Red Blood Cells from Patients with Homozygous Sickle Cell Disease and β-Thalassemia

  1996cites this paper
• Bothrojaracin: a potent two-site-directed thrombin inhibitor.

  1996cites this paper
• Functional consequences of the Ser334-->Pro mutation in a human factor X variant (factor XMarseille).

  1995cites this paper
• Prothrombin Frankfurt: A Dysfunctional Prothrombin Characterized by Substitution of Glu-466 by Ala

  1995cites this paper
• Mapping of the thrombin des-ETW conformation by using site-directed mutants of hirudin. Evidence for the induction of nonlocal modifications by mutagenesis.

  1994cites this paper
• Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity.

  1992cites this paper
• Inherited bleeding disorders.

  1991cites this paper
• (Factor II Deficiency): Report of a Case and Review of Literature

  1991cites this paper
• Hypoprothrombinemia (factor II deficiency): report of a case and review of literature.

  1991cites this paper
• [Hereditary dysprothrombinemia with a mild bleeding tendency (prothrombin Magdeburg)].

  1989cites this paper
• Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thrombin that are critical for heparin and fibrin(ogen) interactions.

  1989cites this paper
• Functional characterization of thrombin Salakta: an abnormal thrombin derived from a human prothrombin variant.

  1988cites this paper
• Prothrombin Tokushima: characterization of dysfunctional thrombin derived from a variant of human prothrombin.

  1987cites this paper
• PROTHROMBIN TOKUSHIMA: A REPLACEMENT OF ARGININE-418 BY TRYPTOPHAN THAT IMPAIRS THE FIBRINOGEN CLOTTING ACTIVITY OF DERIVED THROMBIN TOKUSHIMA

  1987cites this paper
• Prothrombin Poissy: a new variant of human prothrombin

  1987cites this paper
• Prothrombin Tokushima: characterization of dysfunctional thrombin derived from a variant of human prothrombin

  1987cites this paper
• Prothrombin Clamart: prothrombin variant with defective Arg 320-IIe cleavage by factor Xa.

  1986cites this paper
• Molecular defect of prothrombin Barcelona. Substitution of cysteine for arginine at residue 273.

  1986cites this paper
• Congenitally Abnormal Prothrombin and Thrombin a

  1986cites this paper
• On the quantification of prothrombin from different species using Echis carinatus as activator.

  1986cites this paper
• Prothrombin Perija: a new congenital dysprothrombinemia in an Indian family.

  1986cites this paper
• Andere angeborene Koagulopathien

  1985cites this paper